MAOB and major depressive disorder: Furthermore, to clarify whether antiparkinsonian drugs acting on dopaminergic system have commonly the antidepressant action, we compared effects of selegiline on depression-like behavior in CD157 KO mice with those of the antiparkinsonian drugs rasagiline (another MAO-B inhibitor) and pramipexole (a D2/D3 receptor agonist).